News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Mass Resignation from
’s Editorial Board
Catherine Offord | Nov 6, 2017
Nineteen researchers have stepped down after the journal decided not to retract a paper that they say plagiarized the work of a Johns Hopkins biomedical scientist.
Journal Cut from Medline
Katarina Zimmer | Oct 26, 2017
New papers from a cancer journal once named as a possibly predatory publication will no longer appear in the widely used research database.
Parkinson’s Researcher Notches 17 Retracted Papers
Aggie Mika | Sep 13, 2017
Scientific misconduct motivated Yoshihiro Sato’s three additional retractions last month; his institution doesn’t respond.
Macchiarini Retracts Another Paper
Bob Grant | Mar 22, 2017
The embattled thoracic surgeon blames his former employer, the Karolinska Institute, for losing data related to the retracted research.
Top 10 Retractions of 2016
Retraction Watch | Dec 21, 2016
A look at this year’s most memorable retractions
Duke Sued for Millions over Fraudulent Data
Jef Akst | Sep 6, 2016
A lawsuit claims that Duke University and biologist Erin Potts-Kant used bad data in projects funded by dozens of government grants.
TS Picks: August 9, 2016
Bob Grant | Aug 9, 2016
Gene therapy money-back guarantee; the brain benefits from bilingualism; Q&A with a science watchdog
More Retractions for Cancer Researcher
Tanya Lewis | Jun 22, 2016
An institutional investigation has found evidence of image manipulation in two studies coauthored by Bharat Aggarwal.
Journal to Publish Clinical Trial Protocols
Tanya Lewis | May 18, 2016
Following an independent group’s finding of misreported outcomes, the
Annals of Internal Medicine
now requires that authors include clinical trial protocols when submitting their results.
Fraudulent Paper Pulled
Bob Grant | Jan 5, 2016
retracts a study six years after an investigation found that the protein structures it reported were fabricated.